125 related articles for article (PubMed ID: 34863878)
1. APOBEC3, TRIM5α, and BST2 polymorphisms in healthy individuals of various populations with special references to its impact on HIV transmission.
Singh H; Jadhav S; Arif Khan A; Aggarwal SK; Choudhari R; Verma S; Aggarwal S; Gupta V; Singh A; Nain S; Maan HS
Microb Pathog; 2022 Jan; 162():105326. PubMed ID: 34863878
[TBL] [Abstract][Full Text] [Related]
2. Impact of cellular restriction gene (TRIM5α, BST-2) polymorphisms on the acquisition of HIV-1 and disease progression.
Singh H; Samani D; Ghate MV; Gangakhedkar RR
J Gene Med; 2018 Feb; 20(2-3):e3004. PubMed ID: 29282802
[TBL] [Abstract][Full Text] [Related]
3. Protective Role of BST2 Polymorphisms in Mother-to-Child Transmission of HIV-1 and Adult AIDS Progression.
Kamada AJ; Bianco AM; Zupin L; Girardelli M; Matte MC; Medeiros RM; Almeida SE; Rocha MM; Segat L; Chies JA; Kuhn L; Crovella S
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):237-41. PubMed ID: 26885809
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the APOBEC3G gene of Chinese rhesus macaques affect resistance to ubiquitination and degradation mediated by HIV-2 Vif.
Jiang ZQ; Yao XR; Yu H; Lu YE; Liu BL; Liu FL; Jin YB; Zhuo M; Zheng YT; Ling F
Arch Virol; 2019 May; 164(5):1353-1360. PubMed ID: 30859472
[TBL] [Abstract][Full Text] [Related]
5. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
[TBL] [Abstract][Full Text] [Related]
7. Vpu and BST2: Still Not There Yet?
Sato K; Gee P; Koyanagi Y
Front Microbiol; 2012; 3():131. PubMed ID: 22509177
[TBL] [Abstract][Full Text] [Related]
8. Risk association of BST2 gene variants with disease progression in HIV-1 infected Indian cohort.
Gupte DS; Patil A; Selvaa Kumar C; Pandey S; Achrekar SK; Paranjape RS; Jagtap DD
Infect Genet Evol; 2020 Jun; 80():104139. PubMed ID: 31841700
[TBL] [Abstract][Full Text] [Related]
9. Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release.
Jafari M; Guatelli J; Lewinski MK
J Virol; 2014 May; 88(9):5062-78. PubMed ID: 24574397
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and tetherin in a Senegalese cohort of HIV-1-exposed seronegative individuals.
Mous K; Jennes W; Camara M; Seydi M; Daneau G; Mboup S; Kestens L; Van Ostade X
PLoS One; 2012; 7(3):e33934. PubMed ID: 22479480
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Adapts To Replicate in Cells Expressing Common Marmoset APOBEC3G and BST2.
Fernández-Oliva A; Finzi A; Haim H; Menéndez-Arias L; Sodroski J; Pacheco B
J Virol; 2016 Jan; 90(2):725-40. PubMed ID: 26512082
[TBL] [Abstract][Full Text] [Related]
12. The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals.
Dias BDC; Paximadis M; Martinson N; Chaisson RE; Ebrahim O; Tiemessen CT
Infect Genet Evol; 2020 Jun; 80():104216. PubMed ID: 32006707
[TBL] [Abstract][Full Text] [Related]
13. Associations of common variants in the BST2 region with HIV-1 acquisition in African American and European American people who inject drugs.
Hancock DB; Gaddis NC; Levy JL; Bierut LJ; Kral AH; Johnson EO
AIDS; 2015 Apr; 29(7):767-77. PubMed ID: 25985399
[TBL] [Abstract][Full Text] [Related]
14. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
Armitage AE; Deforche K; Welch JJ; Van Laethem K; Camacho R; Rambaut A; Iversen AK
J Virol; 2014 Nov; 88(21):12882-94. PubMed ID: 25165112
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G.
Sakuma R; Noser JA; Ohmine S; Ikeda Y
Gene Ther; 2007 Jan; 14(2):185-9. PubMed ID: 16943852
[TBL] [Abstract][Full Text] [Related]
18. A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
Duan S; Wang S; Song Y; Gao N; Meng L; Gai Y; Zhang Y; Wang S; Wang C; Yu B; Wu J; Yu X
J Biol Chem; 2020 Oct; 295(43):14592-14605. PubMed ID: 32817167
[TBL] [Abstract][Full Text] [Related]
19. Suppression of APOBEC3-mediated restriction of HIV-1 by Vif.
Feng Y; Baig TT; Love RP; Chelico L
Front Microbiol; 2014; 5():450. PubMed ID: 25206352
[TBL] [Abstract][Full Text] [Related]
20. Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly.
Lewinski MK; Jafari M; Zhang H; Opella SJ; Guatelli J
J Biol Chem; 2015 Apr; 290(17):10919-33. PubMed ID: 25759385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
